Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 5659 of 5804
-
New heart drug HRS-5765 takes first step in human safety trial
Knowledge-focused Recruiting nowThe purpose of this phase I study is to evaluate the safety, tolerability, pharmacokinetics (PK) and pharmacodynamics (PD) of HRS-5765 in healthy participants.
Phase: PHASE1 • Sponsor: Chengdu Suncadia Medicine Co., Ltd. • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:37 UTC
-
New thermometer aims to take core temperature from the skin
Knowledge-focused Not yet recruitingThe body temperature measured by the skin is easily affected by the measurement environment such as temperature or humidity, and in some cases, the difference from the central body temperature is particularly large. Therefore, there has been an attempt to develop a new method of …
Sponsor: Yonsei University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:10 UTC
-
New drug BI 3814916 begins first human safety tests
Knowledge-focused Recruiting nowThe main objectives of this trial are to investigate safety, tolerability and pharmacokinetics (PK) of BI 3814916 in healthy male and female trial participants.
Phase: PHASE1 • Sponsor: Boehringer Ingelheim • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:38 UTC
-
Healthy volunteers needed to test drug interaction
Knowledge-focused Recruiting nowThe purpose of the study is to see how itraconazole affects LY4395089 in healthy participants. Blood tests will be performed to investigate how the body processes the study drug and how the study drug affects the body. There will be fifteen inpatient stays at the clinical resear…
Phase: PHASE1 • Sponsor: Eli Lilly and Company • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
New schizophrenia drug candidate begins first human safety tests
Knowledge-focused Not yet recruitingThis study aims to investigate the safety, tolerability and pharmacokinetic characteristics of KR23248 capsules in healthy subjects. This study will be conducted in China. It will enroll male and female participants aged 18 years to 45 years.
Phase: PHASE1 • Sponsor: Jiangxi Kvvit Pharmaceutical Co., Ltd. • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:33 UTC
-
New drug BW-50218 put to first safety test in healthy chinese volunteers
Knowledge-focused OngoingA Phase 1 Study of Single-Dose BW-50218 in Healthy Chinese Participants
Phase: PHASE1 • Sponsor: Shanghai Argo Biopharmaceutical Co., Ltd. • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:03 UTC
-
Which CoQ10 supplement works better? new study aims to find out.
Knowledge-focused Recruiting nowThe goal of this clinical trial is to compare the relative bioavailability of coenzyme Q10 (CoQ10) from acute administrations of a CoQ10 product designed for enhanced absorption versus a standard CoQ10 product in healthy men and women. Participants will be asked to come to the cl…
Phase: NA • Sponsor: Midwest Center for Metabolic and Cardiovascular Research • Aim: Knowledge-focused
Last updated Jul 23, 2026 00:00 UTC
-
Healthy volunteers help scientists measure how two drugs enter skin and blood
Knowledge-focused Recruiting nowThe purpose of this study is to evaluate the interstitial concentrations using the open-flow microperfusion device and plasma pharmacokinetics following multiple doses of povorcitinib or topical ruxolitinib cream in healthy adult participants.
Phase: PHASE1 • Sponsor: Incyte Corporation • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:01 UTC
-
Foam roller showdown: can it beat a real massage?
Knowledge-focused Not yet recruitingObjective: This study aims to compare the effects of two techniques-foam rolling (FR) and therapeutic massage-on reducing the muscle tone in the calf muscles (gastrocnemius and soleus) of healthy individuals. Methods: A randomized, controlled crossover design was used with 40 he…
Phase: NA • Sponsor: Universidad Europea de Madrid • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:29 UTC
-
New drug HS-20136-2 enters first human safety trial
Knowledge-focused Not yet recruitingThis is a randomized, double-blind,placebo-controlled phase I clinical study.The main purpose is to assess the safety and tolerability of single subcutaneous administration of HS-20136-2 injection in healthy participants.
Phase: PHASE1 • Sponsor: Jiangsu Hansoh Pharmaceutical Co., Ltd. • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:01 UTC
-
New kidney disease drug candidate tested in healthy people for first time in asia
Knowledge-focused Not yet recruitingThis is a first time in Asia (FTIA) study of GSK4771261 in healthy participants of Chinese, Japanese, and White/European ancestry. The study will test whether GSK4771261 is safe, well-tolerated, how it is processed in the body, and whether it triggers an immune response.
Phase: PHASE1 • Sponsor: GlaxoSmithKline • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:35 UTC
-
Kinesio tape study aims to uncover muscle secrets
Knowledge-focused Not yet recruitingThe aim of this study is to investigate the effects of kinesio taping applied to the gastrocnemius muscle on muscle oxygenation, pain pressure threshold, and mechanical properties of the muscle in healthy young individuals.
Phase: NA • Sponsor: Okan University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:30 UTC
-
High-Tech training boosts nursing Students' injection skills
Knowledge-focused CompletedThe aim of this study was to evaluate the impact of a skills training program-conducted using augmented reality (AR) and 3D model technologies-on first-year nursing students' knowledge, skills, anxiety, and satisfaction, as well as the retention of learning, regarding the correct…
Phase: NA • Sponsor: Karabuk University • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Radioactive microdose reveals Drug's journey in healthy men
Knowledge-focused Recruiting nowFor this study, the study medicine has been specially prepared to contain radiolabeled carbon \[14C\]. \[14C\] is a naturally occurring radioactive form of the element carbon. Adding a low dose of radiation to the study medicine does not change how the medicine works but helps to…
Phase: PHASE1 • Sponsor: Pfizer • Aim: Knowledge-focused
Last updated Jul 11, 2026 00:00 UTC
-
Prostate surgery lung changes under microscope
Knowledge-focused Not yet recruitingThis study aims to evaluate changes in driving pressure and static lung compliance during HoLEP surgery and to investigate their relationship with surgical and perioperative factors. This study is observational, and no changes will be made to the patients' current treatment proce…
Sponsor: Ankara City Hospital Bilkent • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:37 UTC
-
Lyme disease trial withdrawn before it even started
Disease control TerminatedLyme disease is a public health crisis in the US. It is estimated that over 400,000 cases occur every year with 10-20% of those infected going on to develop Post-Treatment Lyme disease Syndrome (PTLDS). The goal of this study is to investigate if giving Ceftriaxone every 5 days f…
Phase: PHASE1, PHASE2 • Sponsor: Hackensack Meridian Health • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
New enzyme drug tested in healthy volunteers
Knowledge-focused Not yet recruitingThe study is being conducted to evaluate the safety, pharmacokinetics, and immunogenicity of recombinant human hyaluronidase in healthy Chinese adult male subjects.
Phase: PHASE1 • Sponsor: Shanghai Henlius Biotech • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:03 UTC
-
Pfizer tests new drug absorption in healthy volunteers
Knowledge-focused Recruiting nowThe purpose of this study is to learn how different forms of the study medicine called PF-08049820 are absorbed and eliminated in healthy adults. The study will assess whether the study medicine is absorbed differently when taken with or without food. It will also assess absorpti…
Phase: PHASE1 • Sponsor: Pfizer • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Crunch time: study tests if thicker crisps slow down eating
Knowledge-focused Not yet recruitingTo analyse texturally altered crisp products that exhibit variations in hardness and thickness. The aim is to generate knowledge on how these properties influence eating behaviour (number of chews, rate of consumption, etc.), sensory and liking ratings in a fixed-portion laborato…
Phase: NA • Sponsor: PepsiCo Global R&D • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:35 UTC
-
Can better instructions make urine collection easier?
Knowledge-focused Recruiting nowThe aim of this study is to improve the instructions for use and to evaluate the usability of a novel first-void urine collection device.
Phase: NA • Sponsor: Universiteit Antwerpen • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:04 UTC